default author photo

Alicia Budd

Government of the United States of America - Centers for Disease Control and Prevention (CDC)

SCHOLARLY PAPERS

2

DOWNLOADS

160

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Interim Findings: October 2025 – January 2026 Influenza Season in the United States

Number of pages: 18 Posted: 11 Feb 2026
Eduardo Azziz-Baumgartner, Alicia Budd, Justin S. Lee, Danielle Iuliano, Sascha Ellington, Min Levine, Xiao-yu Z. Zheng, Larisa Z. Gubareva, Katherine Adams, Jennifer DeCuir, Catherine H. Bozio, Carrie Reed, Marie K. Kirby, Jefferson M. Jones, Matthew M. Biggerstaff, Shikha Garg, Todd Davis, Tom T. Shimabukuro, Erin T. Burns, Rebecca J. Kondor, Sonja Olsen and Vivien G. Dugan
Government of the United States of America - Influenza Division, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Influenza Division, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Influenza Division, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Influenza Division, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Immunization Safety Office, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC) and Government of the United States of America - Centers for Disease Control and Prevention (CDC)
Downloads 96 (715,072)

Abstract:

Loading...

influenza, genetic, antigen, incidence, vaccine, effectiveness, subclade K

2.

Antiviral Susceptibility Monitoring: Testing Algorithm, Methods, and Findings for Influenza Season, 2023-2024

Number of pages: 27 Posted: 09 Jun 2025
Mira C. Patel, Ha T. Nguyen, Vasiliy P. Mishin, Philippe Noriel Q. Pascua, Chloe Champion, Mercedes Lopez-Esteva, Angiezel Merced-Morales, Alicia Budd, Marie K. Kirby, Benjamin Rambo-Martin, Jennifer Laplante, Allen Bateman, Kirsten St. George, Maureen Sullivan, John Steel, Rebecca J. Kondor and Larisa Gubareva
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), affiliation not provided to SSRN, New York State Department of Health, affiliation not provided to SSRN, New York State Department of Health, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the United States of America - Centers for Disease Control and Prevention (CDC) and affiliation not provided to SSRN
Downloads 64 (924,743)

Abstract:

Loading...

antiviral resistance, IRINA, baloxavir, Neuraminidase inhibitor, oseltamivir, influenza